These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 14738453)

  • 21. Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro.
    Dunnion DJ; Cywinski AL; Tucker VC; Murray AK; Rickinson AB; Coulie P; Browning MJ
    Immunology; 1999 Dec; 98(4):541-50. PubMed ID: 10594686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus monocyte-derived dendritic cells modified to over-express TGF-beta1 exhibit potent veto activity.
    Asiedu C; Dong SS; Pereboev A; Wang W; Navarro J; Curiel DT; Thomas JM
    Transplantation; 2002 Sep; 74(5):629-37. PubMed ID: 12352878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of factor VIII concentrate on antigen-presenting cell (APC)/T-cell interactions in vitro: relevance to inhibitor formation and tolerance induction.
    Hodge G; Han P
    Br J Haematol; 2000 Apr; 109(1):195-200. PubMed ID: 10848800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter.
    Olsson C; Michaëlsson E; Parra E; Pettersson U; Lando PA; Dohlsten M
    Int Immunol; 1998 Apr; 10(4):499-506. PubMed ID: 9620606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent.
    Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
    Scand J Immunol; 1999 Sep; 50(3):242-9. PubMed ID: 10447932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
    Jaiswal AI; Dubey C; Swain SL; Croft M
    Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
    Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
    Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation.
    Bell JJ; Min B; Gregg RK; Lee HH; Zaghouani H
    J Immunol; 2003 Aug; 171(4):1801-8. PubMed ID: 12902480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A.
    Eshima K; Choi Y; Flavell RA
    Int Immunol; 2003 Jul; 15(7):817-26. PubMed ID: 12807820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
    Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
    Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.
    Cella M; Scheidegger D; Palmer-Lehmann K; Lane P; Lanzavecchia A; Alber G
    J Exp Med; 1996 Aug; 184(2):747-52. PubMed ID: 8760829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of self-tolerance by CD80/CD86 interactions.
    Lu P; Wang YL; Linsley PS
    Curr Opin Immunol; 1997 Dec; 9(6):858-62. PubMed ID: 9492990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo.
    Förster E; Krenger W; Joergensen J; Hof R; Geha RS; Holländer GA
    Transplantation; 1999 May; 67(9):1284-7. PubMed ID: 10342324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.